181 related articles for article (PubMed ID: 15283683)
21. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
[TBL] [Abstract][Full Text] [Related]
22. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent.
Curtis Hewitt S; Goulding EH; Eddy EM; Korach KS
Biol Reprod; 2002 Oct; 67(4):1268-77. PubMed ID: 12297545
[TBL] [Abstract][Full Text] [Related]
23. Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
Golledge J; Mangan S; Clancy P
Stroke; 2007 May; 38(5):1501-8. PubMed ID: 17363721
[TBL] [Abstract][Full Text] [Related]
24. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo.
Du L; Ma Y; Liu M; Yan L; Tang H
Virol J; 2017 May; 14(1):96. PubMed ID: 28545573
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats.
Samah M; El-Aidy Ael-R; Tawfik MK; Ewais MM
Eur J Pharmacol; 2012 Aug; 689(1-3):186-93. PubMed ID: 22659583
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
Vikramadithyan RK; Hirata K; Yagyu H; Hu Y; Augustus A; Homma S; Goldberg IJ
J Pharmacol Exp Ther; 2005 May; 313(2):586-93. PubMed ID: 15671204
[TBL] [Abstract][Full Text] [Related]
30. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
Houston KD; Copland JA; Broaddus RR; Gottardis MM; Fischer SM; Walker CL
Cancer Res; 2003 Mar; 63(6):1221-7. PubMed ID: 12649180
[TBL] [Abstract][Full Text] [Related]
32. Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.
Wu W; Celestino J; Milam MR; Schmeler KM; Broaddus RR; Ellenson LH; Lu KH
Int J Gynecol Cancer; 2008; 18(2):329-38. PubMed ID: 18334011
[TBL] [Abstract][Full Text] [Related]
33. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
[TBL] [Abstract][Full Text] [Related]
34. Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor.
Das N; Wang J; Dey SK
Mol Reprod Dev; 1997 Apr; 46(4):499-506. PubMed ID: 9094097
[TBL] [Abstract][Full Text] [Related]
35. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury.
Sivarajah A; Chatterjee PK; Patel NS; Todorovic Z; Hattori Y; Brown PA; Stewart KN; Mota-Filipe H; Cuzzocrea S; Thiemermann C
Am J Nephrol; 2003; 23(4):267-76. PubMed ID: 12840602
[TBL] [Abstract][Full Text] [Related]
36. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.
Chaput E; Saladin R; Silvestre M; Edgar AD
Biochem Biophys Res Commun; 2000 May; 271(2):445-50. PubMed ID: 10799317
[TBL] [Abstract][Full Text] [Related]
37. Uterine responses to feeding soy protein isolate and treatment with 17β-estradiol differ in ovariectomized female rats.
Ronis MJ; Gomez-Acevedo H; Blackburn ML; Cleves MA; Singhal R; Badger TM
Toxicol Appl Pharmacol; 2016 Apr; 297():68-80. PubMed ID: 26945725
[TBL] [Abstract][Full Text] [Related]
38. Canonical Wnt signaling is critical to estrogen-mediated uterine growth.
Hou X; Tan Y; Li M; Dey SK; Das SK
Mol Endocrinol; 2004 Dec; 18(12):3035-49. PubMed ID: 15358837
[TBL] [Abstract][Full Text] [Related]
39. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
